Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "SUIT-026 O2 mt D063"

From Bioblast
 
(2 intermediate revisions by 2 users not shown)
Line 2: Line 2:
|abbr=RET (respiratory control) of [[SUIT-026 AmR mt D064]]
|abbr=RET (respiratory control) of [[SUIT-026 AmR mt D064]]
|description=[[File:1S;2Rot;3D;3c;4Ama.png|400px]]
|description=[[File:1S;2Rot;3D;3c;4Ama.png|400px]]
|info='''B''' - '''[[SUIT-026]]'''  
|info='''B''' - '''[[SUIT-026]]''' - Protocol for the respiratory control of [[SUIT-026 AmR mt D064]]
|application=O2
|application=O2
|SUIT number=D063_1S;2Rot;3D;3c;4Ama
|SUIT number=D063_1S;2Rot;3D;3c;4Ama
}}
}}
::: '''[[MitoPedia: SUIT]]''' - Protocol for the respiratory control of [[SUIT-026 AmR mt D064]]
::: '''[[SUIT protocol pattern]]:'''  1S;2Rot;3D;3c;4Ama


{{Template:SUIT text D063}}
{{Template:SUIT text D063}}


__TOC__
__TOC__
  Communicated by  [[Komlodi T]], [[Iglesias-Gonzalez J]] and [[Gnaiger E]] (last update 2019-06-26)
  Communicated by  [[Komlodi T]], [[Gnaiger E]] (last update 2019-09-24)
 
 
== Representative traces ==
 
[[File:SUIT-026 O2 mt D063 O2 trace.png|600px]]


{{Template:SUIT-026 O2 mt D063}}
{{Template:SUIT-026 O2 mt D063}}
Line 27: Line 30:
::::* [[SUIT-006 O2 mt D022]]: CCP mtprep for S-pathway.
::::* [[SUIT-006 O2 mt D022]]: CCP mtprep for S-pathway.


== Chemicals and syringes ==
{{Template:Chemicals SUIT-026 O2 mt D063}}
::: Suggested stock concentrations are shown in the specific DL-Protocol.





Latest revision as of 00:01, 13 April 2021


high-resolution terminology - matching measurements at high-resolution


SUIT-026 O2 mt D063

Description

1S;2Rot;3D;3c;4Ama.png

Abbreviation: RET (respiratory control) of SUIT-026 AmR mt D064

Reference: B - SUIT-026 - Protocol for the respiratory control of SUIT-026 AmR mt D064

SUIT number: D063_1S;2Rot;3D;3c;4Ama

O2k-Application: O2


SUIT-026 O2 mt D063 has been designed to serve as a respiratory control of the SUIT-026 AmR mt D064 (protocol to study the RET-initiated ROS production in mitochondrial preparations (isolated mitochondria, tissue homogenate and permeabilized cells which are already permeabilized when they are added to the chamber).

Communicated by  Komlodi T, Gnaiger E (last update 2019-09-24)


Representative traces

SUIT-026 O2 mt D063 O2 trace.png

MitoPedia: SUIT

Steps and respiratory states

1S;2Rot;3D;4Ama.png


Step State Pathway Q-junction Comment - Events (E) and Marks (M)
1S SL(n) S CII 1S
2Rot SL(n) S CII 1S;2Rot
3D SP S CII 1S;2Rot;3D
3c SP S CII 1S;2Rot;3D;3c
4Ama ROX 1S;2Rot;3D;3c;4Ama
  • Rox is the residual oxygen consumption in the ROX state, due to oxidative side reactions, estimated after addition of antimycin A (inhibitor of CIII). Rox is subtracted from oxygen flux as a baseline for all respiratory states, to obtain mitochondrial respiration (mt).


Questions.jpg


Click to expand or collaps

Strengths and limitations

  • This protocol serves as a respiratory control (since fluorescence dyes may inhibit components of the ET system) and quality control for the sample for SUIT-026 AmR mt D064.
+ Short protocol.
+ The addition of cytochrome c to assess the mt outer membrane integrity provides a quality control of the sample, which cannot be performed in the protocol with Amplex UltraRed.
- This protocol does not provide information about all the coupling control states (LEAK, OXPHOS and ET). However, it is possible to create a DLPU by additing an Event&Mark for the uncoupler titration (4U) after ADP (3D) to obtain ET-state.


Compare SUIT protocols


Chemicals and syringes

Step Chemical(s) and link(s) Comments
1S Succinate (S)
2Rot Rotenone (Rot)
3D ADP (D)
3c Cytochrome c (c)
4Ama Antimycin A (Ama)
Suggested stock concentrations are shown in the specific DL-Protocol.


References

MitoPedia concepts: SUIT protocol, SUIT B, Find 


MitoPedia methods: Fluorometry